Muriel Vray
Impact in
- Virology top 1%
- HIV Research and Treatment
- Hepatology top 2%
- Hepatitis C virus research
Papers in
- Epidemiology 32
- Hepatitis B Virus Studies 19
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Trevor Andrew Sheldon (2 shared papers)Martin J Buxton (2 shared papers)Thomas D. Szucs (2 shared papers)Ben A. van Hout (2 shared papers)Michael Drummond (1 shared paper)Richard Lewis Prince (1 shared paper)É. Eschwège (4 shared papers)Beverley Balkau (2 shared papers)
- Journals
- PLoS ONE (8 papers)AIDS (5 papers)Vaccine (5 papers)Antiviral Therapy (4 papers)BMC Infectious Diseases (4 papers)
- Partner nations
- FranceSenegalMadagascar
In The Last Decade
Muriel Vray
126 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 149
- Virology 479
- Hepatology 403
- Applied Microbiology and Biotechnology 96
- Infectious Diseases 845
- Molecular Medicine 202
Countries citing papers authored by Muriel Vray
This map shows the geographic impact of Muriel Vray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Vray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Vray more than expected).
Fields of papers citing papers by Muriel Vray
This network shows the impact of papers produced by Muriel Vray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Vray. The network helps show where Muriel Vray may publish in the future.
Co-authors
The 25 scholars most cited alongside Muriel Vray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 471 | |
| 2 | 2015 | 304 | |
| 3 | 2002 | 176 | |
| 4 | 2017 | 133 | |
| 5 | 2014 | 124 | |
| 6 | 2007 | 115 | |
| 7 | 2003 | 82 | |
| 8 | 2016 | 71 | |
| 9 | 2015 | 70 | |
| 10 | 2017 | 69 | |
| 11 | 2018 | 64 | |
| 12 | 2020 | 64 | |
| 13 | 1994 | 59 | |
| 14 | 2018 | 58 | |
| 15 | 2003 | 57 | |
| 16 | 2014 | 56 | |
| 17 | 2018 | 56 | |
| 18 | 2016 | 55 | |
| 19 | 2003 | 55 | |
| 20 | 1994 | 54 |
About Muriel Vray
Muriel Vray is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Virology and Public Health, Environmental and Occupational Health, having authored 131 papers that have together received 3.7k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (19 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers), Hepatitis C virus research (10 papers), HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers), Pharmaceutical Economics and Policy (8 papers), Statistical Methods in Clinical Trials (6 papers) and Healthcare Systems and Practices (5 papers). The work is most often cited by research in Virology (479 citations), Hepatology (403 citations), Applied Microbiology and Biotechnology (96 citations), Infectious Diseases (845 citations) and Molecular Medicine (202 citations). Muriel Vray has collaborated with scholars based in France, Senegal and Madagascar. Frequent co-authors include Trevor Andrew Sheldon, Martin J Buxton, Thomas D. Szucs, Ben A. van Hout, Michael Drummond, Richard Lewis Prince, É. Eschwège, Beverley Balkau, Loïc Chartier and Gilles Peytavin. Their work appears in journals such as PLoS ONE, AIDS, Vaccine, Antiviral Therapy and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.